LONDON — Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck on Thursday, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.
Democracy Dies in Darkness
Britain authorizes Merck’s molnupiravir, the world’s first approval of oral covid-19 treatment pill
and
Updated November 4, 2021 at 9:32 a.m. EDT|Published November 4, 2021 at 6:32 a.m. EDT